Nashashibi; Imad

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nashashibi; Imad.The latest application filed is for "immunoassay for mitragynine".

Company Profile

2.15.24

Nashashibi; Imad - San Jose CA
- San Jose CA US
Nashashibi; Imad - Hayward CA
Nashashibi; Imad - Milpitas CA
Nashashibi, Imad - Mountain View CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Immunoassay For Mitragynine App 20200308306 - Xu; Gupoing ; et al.	2020-10-01
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 9,925,189 - Chen , et al. March 27, 2	2018-03-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20180021335 - Chen; Xin ; et al.	2018-01-25
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 9,737,537 - Chen , et al. August 22, 2	2017-08-22
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20170105993 - Chen; Xin ; et al.	2017-04-20
Bicyclic agonists of GPR131 and uses thereof Grant 9,593,109 - Song , et al. March 14, 2	2017-03-14
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20150239881 - Chen; Xin ; et al.	2015-08-27
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,975,258 - Chen , et al. March 10, 2	2015-03-10
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 08921350 -	2014-12-30
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,921,350 - Chen , et al. December 30, 2	2014-12-30
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,846,675 - Ma , et al. September 30, 2	2014-09-30
Gpr120 Receptor Agonists And Uses Thereof App 20140121246 - Shi; Dong Fang ; et al.	2014-05-01
Agonists of GPR131 and uses thereof Grant 8,703,776 - Novack , et al. April 22, 2	2014-04-22
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20140024830 - Chen; Xin ; et al.	2014-01-23
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20130281691 - Chen; Xin ; et al.	2013-10-24
Agonists Of Gpr131 And Uses Thereof App 20130059856 - Novack; Aaron Robert ; et al.	2013-03-07
Bicyclic Agonists Of Gpr131 And Uses Thereof App 20130059845 - SONG; Jiangao ; et al.	2013-03-07
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20120322804 - Ma; Jingyuan ; et al.	2012-12-20
Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,288,384 - Chen , et al. October 16, 2	2012-10-16
2,4-disubsituted thiazoles and pharmaceutical compositions thereof Grant 8,227,495 - Chen , et al. July 24, 2	2012-07-24
Aryl Gpr119 Agonists And Uses Thereof App 20120184572 - Song; Jiangao ; et al.	2012-07-19
N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders Grant 8,183,381 - Ma , et al. May 22, 2	2012-05-22
Preparation Of 5-ethyl-2--pyrimidine App 20110313160 - Chen; Xin ; et al.	2011-12-22
Aryl Gpr119 Agonists And Uses Thereof App 20110294836 - Song; Jiangao ; et al.	2011-12-01
Aryl Gpr120 Receptor Agonists And Uses Thereof App 20100216827 - Ma; Jingyuan ; et al.	2010-08-26
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20100130511 - CHEN; XIN ; et al.	2010-05-27
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20100087465 - Chen; Xin ; et al.	2010-04-08
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-- yl}-pyrimidine Grant 7,638,541 - Chen , et al. December 29, 2	2009-12-29
N-linked Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20090137590 - Ma; Jingyuan ; et al.	2009-05-28
Heterocyclic Receptor Agonists For The Treatment Of Diabetes And Metabolic Disorders App 20090054475 - Chen; Xin ; et al.	2009-02-26
Heterocyclic amides and sulfonamides App 20060199821 - Tester; Richard ; et al.	2006-09-07
Azaindole derivatives as inhibitors of p38 kinase App 20050288299 - Mavunkel, Babu J. ; et al.	2005-12-29

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.